REBECCA MCCOLLAUM: Open Payments
NPI 1669658969 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,177 in 209 payments from 25 companies in 2025. Trend: 2023 $19,805 · 2024 $63,695 · 2025 $60,177
Speaker / faculty: $46,030Food & beverage: $6,215Travel & lodging: $5,618Consulting: $2,215Education: $99
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 48 | $20,174 |
| Janssen Biotech, Inc. | 30 | $13,386 |
| ABBVIE INC. | 42 | $11,696 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $9,113 |
| Madrigal Pharmaceuticals | 11 | $1,860 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $1,397 |
| Phathom Pharmaceuticals, Inc. | 6 | $897 |
| PFIZER INC. | 10 | $327 |
| Merit Medical Systems Inc | 2 | $239 |
| QOL Medical, LLC | 3 | $175 |
Products named: OMVOH, TREMFYA, ENTYVIO, SKYRIZI, RINVOQ, REZDIFFRA, STELARA, TRULANCE.
Industry payments across AZ — which companies pay providers there.
